Lamez 50 Tablet DT contains Lamotrigine 50 mg, an anticonvulsant medication primarily indicated for the treatment of epilepsy and bipolar disorder. Lamotrigine acts by stabilizing neuronal membranes through inhibition of voltage-sensitive sodium channels, thereby modulating the release of excitatory neurotransmitters such as glutamate and aspartate. This mechanism helps in reducing the frequency and severity of seizures in patients with partial seizures, primary generalized tonic-clonic seizures, and seizures associated with Lennox-Gastaut syndrome. Additionally, Lamotrigine is effective as a mood stabilizer in managing the depressive episodes of bipolar disorder, contributing to the prevention of mood swings. Lamez 50 Tablet DT is formulated as a dispersible tablet, allowing for rapid disintegration in the oral cavity without the need for water, enhancing patient compliance, especially in those with swallowing difficulties. The dosage should be individualized based on the patient’s clinical response and tolerability, with gradual titration recommended to minimize the risk of adverse effects such as rash, dizziness, headache, and nausea. Caution is advised in patients with hypersensitivity to Lamotrigine or a history of serious dermatologic reactions. Regular monitoring and adherence to prescribed dosing schedules are essential for optimal therapeutic outcomes.